» Articles » PMID: 26598112

Clearance of HBV DNA in Immunized Children Born to HBsAg-positive Mothers, Years After Being Diagnosed with Occult HBV Infection

Overview
Journal J Viral Hepat
Specialty Gastroenterology
Date 2015 Nov 25
PMID 26598112
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In a previous study, we observed immunoprophylaxis failure due to occult hepatitis B virus (HBV) infection (OBI) despite the presence of adequate levels of anti-HBs in 21 (28%) of 75 children born to HBsAg-positive mothers. The aim of the study was to explore the maintenance of this cryptic condition in this population. Of 21 OBI-positive children, 17 were enrolled. HBV serological profiles were determined by enzyme-linked immunosorbent assay. Highly sensitive real-time and standard PCR followed by direct sequencing were applied in positive cases. The mean age (±SD) of studied patients was 6.57 ± 2.75 years. All children still were negative for HBsAg. All but one (94%) were negative for HBV DNA. Only two children were positive for anti-HBc. The results of the most recent anti-HBs titration showed that 4 (23.5%) and 13 (76.5%) had low (<10 IU/mL) and adequate (>10 IU/mL) levels of anti-HBs, respectively. The only still OBI-positive patient had an HBV DNA level of 50 copy/mL, carried the G145R mutation when tested in 2009 and again in 2013 in the 'a' determinant region of the surface protein. Further follow-up showed that after 18 months, he was negative for HBV DNA. In high-risk children, the initial HBV DNA positivity early in the life (vertical infection) does not necessarily indicate a prolonged persistence of HBV DNA (occult infection). Adequate levels of anti-HBs after vaccine and hepatitis B immune globulin immunoprophylaxis following birth could eventually clear the virus as time goes by. Periodic monitoring of these children at certain time intervals is highly recommended.

Citing Articles

An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination.

Delghandi S, Raoufinia R, Shahtahmasbi S, Meshkat Z, Gouklani H, Gholoobi A Heliyon. 2024; 10(17):e37097.

PMID: 39281486 PMC: 11402251. DOI: 10.1016/j.heliyon.2024.e37097.


Humoral Immune Memory to Hepatitis B Vaccine after Primary Vaccination of Children and Adolescents in Assiut, Egypt.

Salama I, Sami S, Elserougy S, Emam H, Salama S, Elhariri H Oman Med J. 2020; 35(5):e175.

PMID: 33083033 PMC: 7538637. DOI: 10.5001/omj.2020.117.


Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study.

Li A, Liu Z, Song Y, Xiao Y, Jiang J, Li L Emerg Microbes Infect. 2020; 9(1):1881-1891.

PMID: 32779526 PMC: 7473118. DOI: 10.1080/22221751.2020.1808533.


Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.

Prabdial-Sing N, Makhathini L, Smit S, Manamela M, Motaze N, Cohen C PLoS One. 2019; 14(5):e0217415.

PMID: 31150445 PMC: 6544234. DOI: 10.1371/journal.pone.0217415.


Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study.

Lu Y, Liu Y, Nie J, Liang X, Yan L, Wang F PLoS One. 2016; 11(11):e0166317.

PMID: 27835694 PMC: 5106040. DOI: 10.1371/journal.pone.0166317.